ABCL
Abcellera Biologics Inc
12.50$
+4.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.9% | -25.7% | +462.2% | +0.7% | -147.3% | – | +6.9% | +2.5% | +24.2% | -3.7% | -40.2% | – | |
| – | +3.7% | +5.8% | +2.1% | -3.5% | -11.3% | -2.9% | -3.9% | -2.2% | -7.1% | -6.9% | +2.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -80.3% | -2,014.8% | – | – | – | – | -260.6% | – | – | – | – | – | |
| – | -29.0% | +67.3% | -18.0% | -6.1% | -15.9% | -32.0% | +25.7% | -33.2% | +10.2% | -61.1% | -44.3% | – | |
| – | +90.2% | – | +72.2% | -92.3% | +805.2% | -77.8% | -500.9% | – | +105.9% | -133.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -43.2% | -24.8% | -7.7% | +20.6% | +31.5% | +44.1% | -156.5% | – | -44.2% | +74.8% | +88.9% | – | |
| – | – | – | – | -187.6% | – | -90.1% | -2,372.3% | – | – | -218.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.